Araştırma Makalesi
BibTex RIS Kaynak Göster

Evaluation of changes in meibomian glands in polycystic ovary syndrome by noncontact infrared meibography

Yıl 2019, Cilt: 3 Sayı: 9, 711 - 714, 01.09.2019
https://doi.org/10.28982/josam.618249

Öz

Aim: The human meibomian gland contains several overexpressed genes that are related to lipid dynamics and glandular structure. Meibomian gland dysfunction (MGD) was found to be associated with significant changes in these genes. The aim of this study was to compare the changes in meibomian glands in patients with polycystic ovary syndrome (PCOS) and healthy young women by non-contact meibography for the first time.

Methods: A total of 58 right eyes belonging to 28 patients with PCOS and 30 healthy women in the control group were included in this case-control study. The ocular surface and eyelid margins were evaluated with slit lamp examinations. Participants were asked about dry eye symptoms. Schirmer and tear film break time (TBUT) tests were performed consecutively. The morphology of the meibomian glands was observed with non-contact meibography and scored with the meiboscore.

Results: Dry eye symptoms were more prevalent and average TBUT was shorter in PCOS patients (p=0.001, p=0.02, respectively). However, Schirmer test results did not differ among the PCOS and control groups (p= 0.47). The meiboscores for upper eyelids and total eyelids were significantly higher in the PCOS group (P=0.001 and P=0.004, respectively), suggesting that PCOS is accompanied by meibomian gland dropout.

Conclusion: In this study, we found that the morphological status of the meibomian gland and the ocular surface were in worse condition in PCOS patients than in the normal controls, and we successfully observed the loss of meibomian gland in PCOS patients through non-contact meibography.

Kaynakça

  • 1. Pelit A, Aydın P. Oküler yaşlanma. Geriatri. 2001;4:28-32.
  • 2. Puderbach S, Stolze HH. Tear ferning and other lacrimal tests in normal persons of different ages. Int Ophthalmol. 1991;15:391-5.
  • 3. Truong S, Cole N, Stapleton F, Golebiowski B. Sex hormones and the dry eye. Clin Exp Optom. 2014;97:324-36.
  • 4. Rocha EM, Wickham LA, da Silveira LA, Krenzer KL, Yu FS, Toda I, et al. Identification of androjen receptor protein and 5alfa reductase mRNA in human ocular tissues. BJ Ophthalmol. 2000;84:76-84.
  • 5. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):1930-7.
  • 6. Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-7.
  • 7. Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Fukuoka S, et al. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology. 2009;116:2058-63.
  • 8. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008;115:911-5.
  • 9. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5:75-92.
  • 10. Ding J, Sullivan DA. Aging and dry eye disease. Exp Gerontol. 2012;47:483-90.
  • 11. Arita R, Fukuoka S, Morishige N. Meibomian gland dysfunction and contact lens discomfort. Eye Contact Lens. 2017;43:17-22.
  • 12. Ding J, Liu Y, Sullivan DA. Effects of insulin and high glucose on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2015;56:7814-20.
  • 13. Machalińska A, Zakrzewska A, Markowska A, Safranow K, Wiszniewska B, Parafiniuk M, et al. Morphological and functional evaluation of meibomian gland dysfunction in rosacea patients. Curr Eye Res. 2016;41:1029-34.
  • 14. Suzuki T, Morishige N, Arita R, Koh S, Sakimoto T, Shirakawa R, et al. Morphological changes in the meibomian glands of patients with phlyctenular keratitis: a multicenter cross-sectional study. BMC Ophthalmol. 2016;16:178.
  • 15. Schröder A, Abrar DB, Hampel U, Schicht M, Paulsen F, Garreis F. In vitro effects of sex hormones in human meibomian gland epithelial cells. Exp Eye Res. 2016;151:190-202.
  • 16. Sulivan DA, Yamagami H, Liu M, Stegall RJ, Schirra F, Suzuki T, et al. Sex steroids, the meibomian gland and evaporative dry eye. In: David A. Sullivan, Michael E. Stern, Kazuo Tsubota, Darlene A. Dartt, Rose M. Sullivan, B. Britt Bromberg, editors. Lacrimal Gland, Tear Film, and Dry Eye Syndromes; 3. New York: Springer Science; 2002. p.389-400.
  • 17. Yavas GF, Ozturk F, Kusbeci T, Ermis SS, Yilmazer M, Cevrioglu S, et al. Meibomian gland alterations in polycystic ovary syndrome. Curr Eye Res. 2008;33:133-8.
  • 18. Baser G, Yildiz N, Calan M. Evaluation of meibomian gland dysfunction in polycystic ovary syndrome and obesity. Curr Eye Res. 2017;42:661-5.
  • 19. Liu S, Richards SM, Lo K, Hatton M, Fay A, Sullivan DA. Changes in gene expression in human meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52:2727-40.
  • 20. Sheehan MT. Polycystic Ovarian Syndrome: Diagnosis and Management. Clin Med Res. 2014;2:13-27.
  • 21. Amiri M, Ramezani Tehrani F, Nahidi F, Kabir A, Azizi F, Carmina E. Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins. Metabolism. 2017;73:22-35.
  • 22. Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online. 2004;8:644-8.
  • 23. Bonini S, Mantelli F, Moretti C, Lambiase A, Bonini S, Micera A. Itchy-dry eye associated with polycystic ovary syndrome. Am J Ophthalmol. 2007;143:763-71.
  • 24. Nien CJ, Massei S, Lin G, Nabavi C, Tao J, Brown DJ, et al. Effects of age and dysfunction on human meibomian glands. Arch Ophthalmol. 2011;129:462-9.
  • 25. Machalińska A, Zakrzewska A, Safranow K, Wiszniewska B, Machaliński B. Risk factors and symptoms of meibomian gland loss in a healthy population. J Ophthalmol. 2016;2016:7526120.
  • 26. Den S, Shimizu K, Ikeda T, Tsubota K, Shimmura S, Shimazaki J. Association between meibomian gland changes and aging, sex, or tear function. Cornea. 2006;25:651-5.
  • 27. Mizoguchi T, Arita R, Fukuoka S, Morishige N. Morphology and function of meibomian glands and other tear film parameters in junior high school students. Cornea 2017;36:922-6.

Polikistik over sendromu’nda meibomian bezlerdeki değişikliklerin kontakt olmayan kızılötesi meibografi ile değerlendirilmesi

Yıl 2019, Cilt: 3 Sayı: 9, 711 - 714, 01.09.2019
https://doi.org/10.28982/josam.618249

Öz

Amaç: İnsan meibomian bezi lipid dinamikleri ve glandüler yapı ile bağlantılı, aşırı eksprese edilmiş birkaç gen içerir; ve meibomian bez disfonksiyonunun (MBD) bu genlerdeki önemli değişikliklerle ilişkili olduğu bulunmuştur. Bu çalışmanın amacı, ilk kez temassız meibografi ile polikistik over sendromlu (PKOS) hastalarda ve sağlıklı genç kadınlarda meibomian bezlerindeki değişiklikleri karşılaştırmaktır.

Yöntemler: Bu olgu-kontrol çalışmasına PKOS'lu 28 hasta ve kontrol grubundaki 30 sağlıklı kadının toplam 58 sağ gözü dahil edildi. Oküler yüzey ve göz kapağı kenarları yarık lamba incelemeleri ile yapıldı. Katılımcılara kuru göz semptomları hakkında sorular soruldu. Schirmer ve gözyaşı kırılma zamanı (GKZ) testleri sırasıyla tamamlanmıştır. Meibomian bezlerinin morfolojisi temassız meibografi ile gözlendi ve meiboscore kullanılarak skorlandı.

Bulgular: PKOS'da kuru göz semptomları daha sık görülmüştür (P=0,001). PKOS'da ortalama GKZ daha kısaydı (P=0,02). Bununla birlikte Schirmer test sonuçları PKOS ve kontrol grubu arasında farklı değildi (P=0,47). Ek olarak, PKOS'un meibomian bez kaybı ile birlikte olduğunu düşündürecek şekilde, üst göz kapakları ve toplam göz kapakları için meibomian bez skorları, PKOS'da kontrol grubundan anlamlı olarak daha yüksekti (sırasıyla, P=0,001 ve P=0,004). 

Sonuç: Bu çalışmada, PKOS'lu hastalarda meibomian bezinin morfolojik durumunun ve oküler yüzey durumunun normal kontrollerden daha kötü olduğunu ve PKOS'lu hastalarda temassız meibografi ile meibomian bezinin kaybını başarıyla gözlemledik.

Kaynakça

  • 1. Pelit A, Aydın P. Oküler yaşlanma. Geriatri. 2001;4:28-32.
  • 2. Puderbach S, Stolze HH. Tear ferning and other lacrimal tests in normal persons of different ages. Int Ophthalmol. 1991;15:391-5.
  • 3. Truong S, Cole N, Stapleton F, Golebiowski B. Sex hormones and the dry eye. Clin Exp Optom. 2014;97:324-36.
  • 4. Rocha EM, Wickham LA, da Silveira LA, Krenzer KL, Yu FS, Toda I, et al. Identification of androjen receptor protein and 5alfa reductase mRNA in human ocular tissues. BJ Ophthalmol. 2000;84:76-84.
  • 5. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):1930-7.
  • 6. Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-7.
  • 7. Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Fukuoka S, et al. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology. 2009;116:2058-63.
  • 8. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008;115:911-5.
  • 9. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5:75-92.
  • 10. Ding J, Sullivan DA. Aging and dry eye disease. Exp Gerontol. 2012;47:483-90.
  • 11. Arita R, Fukuoka S, Morishige N. Meibomian gland dysfunction and contact lens discomfort. Eye Contact Lens. 2017;43:17-22.
  • 12. Ding J, Liu Y, Sullivan DA. Effects of insulin and high glucose on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2015;56:7814-20.
  • 13. Machalińska A, Zakrzewska A, Markowska A, Safranow K, Wiszniewska B, Parafiniuk M, et al. Morphological and functional evaluation of meibomian gland dysfunction in rosacea patients. Curr Eye Res. 2016;41:1029-34.
  • 14. Suzuki T, Morishige N, Arita R, Koh S, Sakimoto T, Shirakawa R, et al. Morphological changes in the meibomian glands of patients with phlyctenular keratitis: a multicenter cross-sectional study. BMC Ophthalmol. 2016;16:178.
  • 15. Schröder A, Abrar DB, Hampel U, Schicht M, Paulsen F, Garreis F. In vitro effects of sex hormones in human meibomian gland epithelial cells. Exp Eye Res. 2016;151:190-202.
  • 16. Sulivan DA, Yamagami H, Liu M, Stegall RJ, Schirra F, Suzuki T, et al. Sex steroids, the meibomian gland and evaporative dry eye. In: David A. Sullivan, Michael E. Stern, Kazuo Tsubota, Darlene A. Dartt, Rose M. Sullivan, B. Britt Bromberg, editors. Lacrimal Gland, Tear Film, and Dry Eye Syndromes; 3. New York: Springer Science; 2002. p.389-400.
  • 17. Yavas GF, Ozturk F, Kusbeci T, Ermis SS, Yilmazer M, Cevrioglu S, et al. Meibomian gland alterations in polycystic ovary syndrome. Curr Eye Res. 2008;33:133-8.
  • 18. Baser G, Yildiz N, Calan M. Evaluation of meibomian gland dysfunction in polycystic ovary syndrome and obesity. Curr Eye Res. 2017;42:661-5.
  • 19. Liu S, Richards SM, Lo K, Hatton M, Fay A, Sullivan DA. Changes in gene expression in human meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52:2727-40.
  • 20. Sheehan MT. Polycystic Ovarian Syndrome: Diagnosis and Management. Clin Med Res. 2014;2:13-27.
  • 21. Amiri M, Ramezani Tehrani F, Nahidi F, Kabir A, Azizi F, Carmina E. Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins. Metabolism. 2017;73:22-35.
  • 22. Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online. 2004;8:644-8.
  • 23. Bonini S, Mantelli F, Moretti C, Lambiase A, Bonini S, Micera A. Itchy-dry eye associated with polycystic ovary syndrome. Am J Ophthalmol. 2007;143:763-71.
  • 24. Nien CJ, Massei S, Lin G, Nabavi C, Tao J, Brown DJ, et al. Effects of age and dysfunction on human meibomian glands. Arch Ophthalmol. 2011;129:462-9.
  • 25. Machalińska A, Zakrzewska A, Safranow K, Wiszniewska B, Machaliński B. Risk factors and symptoms of meibomian gland loss in a healthy population. J Ophthalmol. 2016;2016:7526120.
  • 26. Den S, Shimizu K, Ikeda T, Tsubota K, Shimmura S, Shimazaki J. Association between meibomian gland changes and aging, sex, or tear function. Cornea. 2006;25:651-5.
  • 27. Mizoguchi T, Arita R, Fukuoka S, Morishige N. Morphology and function of meibomian glands and other tear film parameters in junior high school students. Cornea 2017;36:922-6.
Toplam 27 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Göz Hastalıkları
Bölüm Araştırma makalesi
Yazarlar

Yaran Koban 0000-0002-4981-8001

Rulin Deniz 0000-0002-7306-8212

Yakup Baykuş 0000-0001-5730-8477

Lokman Balyen 0000-0003-4298-7256

Hüseyin Çelik Bu kişi benim 0000-0002-2455-9381

Yayımlanma Tarihi 1 Eylül 2019
Yayımlandığı Sayı Yıl 2019 Cilt: 3 Sayı: 9

Kaynak Göster

APA Koban, Y., Deniz, R., Baykuş, Y., Balyen, L., vd. (2019). Evaluation of changes in meibomian glands in polycystic ovary syndrome by noncontact infrared meibography. Journal of Surgery and Medicine, 3(9), 711-714. https://doi.org/10.28982/josam.618249
AMA Koban Y, Deniz R, Baykuş Y, Balyen L, Çelik H. Evaluation of changes in meibomian glands in polycystic ovary syndrome by noncontact infrared meibography. J Surg Med. Eylül 2019;3(9):711-714. doi:10.28982/josam.618249
Chicago Koban, Yaran, Rulin Deniz, Yakup Baykuş, Lokman Balyen, ve Hüseyin Çelik. “Evaluation of Changes in Meibomian Glands in Polycystic Ovary Syndrome by Noncontact Infrared Meibography”. Journal of Surgery and Medicine 3, sy. 9 (Eylül 2019): 711-14. https://doi.org/10.28982/josam.618249.
EndNote Koban Y, Deniz R, Baykuş Y, Balyen L, Çelik H (01 Eylül 2019) Evaluation of changes in meibomian glands in polycystic ovary syndrome by noncontact infrared meibography. Journal of Surgery and Medicine 3 9 711–714.
IEEE Y. Koban, R. Deniz, Y. Baykuş, L. Balyen, ve H. Çelik, “Evaluation of changes in meibomian glands in polycystic ovary syndrome by noncontact infrared meibography”, J Surg Med, c. 3, sy. 9, ss. 711–714, 2019, doi: 10.28982/josam.618249.
ISNAD Koban, Yaran vd. “Evaluation of Changes in Meibomian Glands in Polycystic Ovary Syndrome by Noncontact Infrared Meibography”. Journal of Surgery and Medicine 3/9 (Eylül 2019), 711-714. https://doi.org/10.28982/josam.618249.
JAMA Koban Y, Deniz R, Baykuş Y, Balyen L, Çelik H. Evaluation of changes in meibomian glands in polycystic ovary syndrome by noncontact infrared meibography. J Surg Med. 2019;3:711–714.
MLA Koban, Yaran vd. “Evaluation of Changes in Meibomian Glands in Polycystic Ovary Syndrome by Noncontact Infrared Meibography”. Journal of Surgery and Medicine, c. 3, sy. 9, 2019, ss. 711-4, doi:10.28982/josam.618249.
Vancouver Koban Y, Deniz R, Baykuş Y, Balyen L, Çelik H. Evaluation of changes in meibomian glands in polycystic ovary syndrome by noncontact infrared meibography. J Surg Med. 2019;3(9):711-4.